Grant: Idea to Innovation
University of Ottawa
$120,000.00
Production of a novel polyphenol- and antioxidant-enriched blueberry composition for use as a natural health product
EF 2014-15
Résumé
Naturally occurring compounds and dietary antioxidants of fruits are increasingly suggested to have beneficial and preventative effects in numerous chronic disease such as cancer, cardiovascular disease , diabetes, and immune and neurodegenerative disease. Our research revealed that fermentation of blueberry (Biotransformed Blueberry Juice or BBJ), using a novel bacterium isolated from the blueberry skin microflora by our lab greatly increased its antioxidant potential, endowed it with novel anti-inflammatory, antidiabetic and other biological activities. In addition, in collaboration with the International Agency for Research on Cancer, we have recently demonstrated that BBJ decreases the formation of cancer stem cells by delaying the development of mammary carcinoma tumors in vivo, and significantly inhibits the metastasis of the highly metastasizing cell line 4T1 to the lungs in murine model of breast cancer. This novel technology is actually protected under 1 issued patent (US 8,617,870) 3 pending patent applications (US 12/541,714, US 14,138,553 and US Prov.61/811,076). The technology has attracted tremendous interest in the natural supplements industry as an evidence based transformation method that supports its relevance and potential uses in nutraceutical or dietary supplement applications. The aim of this proposal is to enhance the value to the existing intellectual property (IP) by refining/optimizing the production process and better characterizing the product profile. The specific objectives are: 1) Refine the BBJ production by optimizing the fermentation conditions, 2) Establish a validated quality control method for standardization, and 3) Complete a bioassay-guided fractionation using anti-inflammatory cell line models. This project will certainly accelerate the pre-commercialization phase and position the technology for follow-on safety studies and a phase 1 clinical trial. The outcome will be to translate the technology into commercial applications and strengthen our ongoing business developing and licensing activities.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
463155-2014
Name nom
Matar, Chantal
Department département
Health Sciences, Faculty of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
120000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6100
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food science and technology
Research subject fr
Science et technologie de l'alimentation
Partie
1
Nb partie
1
Application title
Production of a novel polyphenol- and antioxidant-enriched blueberry composition for use as a natural health product
Keyword
NSERC
Application summary
Naturally occurring compounds and dietary antioxidants of fruits are increasingly suggested to have beneficial and preventative effects in numerous chronic disease such as cancer, cardiovascular disease , diabetes, and immune and neurodegenerative disease. Our research revealed that fermentation of blueberry (Biotransformed Blueberry Juice or BBJ), using a novel bacterium isolated from the blueberry skin microflora by our lab greatly increased its antioxidant potential, endowed it with novel anti-inflammatory, antidiabetic and other biological activities. In addition, in collaboration with the International Agency for Research on Cancer, we have recently demonstrated that BBJ decreases the formation of cancer stem cells by delaying the development of mammary carcinoma tumors in vivo, and significantly inhibits the metastasis of the highly metastasizing cell line 4T1 to the lungs in murine model of breast cancer. This novel technology is actually protected under 1 issued patent (US 8,617,870) 3 pending patent applications (US 12/541,714, US 14,138,553 and US Prov.61/811,076). The technology has attracted tremendous interest in the natural supplements industry as an evidence based transformation method that supports its relevance and potential uses in nutraceutical or dietary supplement applications. The aim of this proposal is to enhance the value to the existing intellectual property (IP) by refining/optimizing the production process and better characterizing the product profile. The specific objectives are: 1) Refine the BBJ production by optimizing the fermentation conditions, 2) Establish a validated quality control method for standardization, and 3) Complete a bioassay-guided fractionation using anti-inflammatory cell line models. This project will certainly accelerate the pre-commercialization phase and position the technology for follow-on safety studies and a phase 1 clinical trial. The outcome will be to translate the technology into commercial applications and strengthen our ongoing business developing and licensing activities.